Emmanuel J Favaloro/LinkedIn
Mar 1, 2026, 09:35
Emmanuel J Favaloro: When Tallied Together, Rare Bleeding Disorders Are Not So Rare
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared on LinkedIn:
”28th February is Rare Disease Day.
There are a plethora of rare bleeding disorders, when tallied become not at all rare.
Several rare bleeding disorders, and their management can be found in this issue of Seminars in Thrombosis and Hemostasis.”
Stay updated with Hemostasis Today.
-
Mar 1, 2026, 09:10Satyam Arora: A Key Gap In Standardized Protocols for Pediatric Massive Transfusion
-
Mar 1, 2026, 08:46Heghine Khachatryan: The Future of Anticoagulation Beyond DOACs
-
Mar 1, 2026, 05:44Ilenia Calcaterra: Innovation In Rare Diseases Is Never Abstract
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro